| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. (VNDA) has 1 insider with recent SEC Form 4 filings, including 0 buys and 21 sells. VNDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.34M | $14.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2019 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 142,409 | $16.95 | $2,413,728.82 | -5.4% | |
| Aug 26, 2019 | Dugan Richard W | Director | Sale+OE | 15,000 | $14.85 | $222,750.00 | -29.5% | |
| Aug 14, 2019 | Williams Timothy69 | SVP &General Counsel | Sell | 2,575 | $14.69 | $37,829.33 | -4.3% | |
| May 21, 2019 | Polymeropoulos Mihael Hristos77 | President And CEO | Sale+OE | 217,515 | $15.35 | $3,338,725.46 | -5.7% | |
| Mar 4, 2019 | Reverberi Gian Piero | SVP &Chief Commercial Officer | Sell | 881 | $20.04 | $17,655.06 | -0.3% | |
| Mar 4, 2019 | Polymeropoulos Mihael Hristos77 | President And CEO | Sell | 44,666 | $19.53 | $872,225.56 | -1.8% | |
| Mar 4, 2019 | Kelly James Patrick | EVP &Chief Financial Officer | Sell | 13,727 | $19.98 | $274,232.51 | -3.1% | |
| Mar 4, 2019 | Birznieks Gunther61 | SVP, Business Development | Sell | 12,529 | $19.96 | $250,091.99 | -3.9% | |
| Jan 3, 2019 | Polymeropoulos Mihael Hristos77 | President And CEO | Sell | 15,236 | $26.36 | $401,662.66 | -0.4% | |
| Jan 3, 2019 | Birznieks Gunther61 | SVP, Business Development | Sell | 6,061 | $26.37 | $159,809.93 | -1.5% |